Pharmaceuticals and Biotechnology Asset Purchase Agreements Analysis Report 2025: Everything a Prospective Dealmaker Needs to Know About Business, Product, Royalty, and ...

The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.The report provides access to asset purchase deal payment terms as ...

Pharmaceuticals and Biotechnology Joint Venture Agreements Analysis Report 2025: Track Trends, Benchmark Valuations, and Access Detailed Contract Terms from 2016 Onward

The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of joint venture deals ...
The Daily Princetonian

Touching history in the Princeton University Numismatic Collection

Princeton University’s Numismatic Collection is a way to come into direct contact with the past. In addition to students ...

Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.
Open Heart

Comparing access to, and outcomes following, TAVI by biological sex

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...